CO5700759A2 - Nuevas diamidas del acido pirimidin-4, 6-dicarboxilixo para la inhibicion selectiva de colagenasas - Google Patents

Nuevas diamidas del acido pirimidin-4, 6-dicarboxilixo para la inhibicion selectiva de colagenasas

Info

Publication number
CO5700759A2
CO5700759A2 CO05041024A CO05041024A CO5700759A2 CO 5700759 A2 CO5700759 A2 CO 5700759A2 CO 05041024 A CO05041024 A CO 05041024A CO 05041024 A CO05041024 A CO 05041024A CO 5700759 A2 CO5700759 A2 CO 5700759A2
Authority
CO
Colombia
Prior art keywords
alkyl
independently
nitrogen
aryl
compound
Prior art date
Application number
CO05041024A
Other languages
English (en)
Inventor
Otmar Klingler
Reinhard Kirsch
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10251019A external-priority patent/DE10251019A1/de
Priority claimed from DE10254092A external-priority patent/DE10254092A1/de
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of CO5700759A2 publication Critical patent/CO5700759A2/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

1.- Un compuesto de la fórmula I y/o todas las formas estereoisómeras del compuesto de la fórmula I y/o mezclas de estas formas en cualquier relación, y/o una sal fisiológicamente tolerada del compuesto de la fórmula I, en la que para el caso a) R1 es un átomo de hidrógeno o -alquil-(C1-C6), R2 es -alquil-(C1-C6), en el que alquilo está una, dos o tres veces sustituido con 1. alquil- (C1-C6) -O-aril- (C6-C14), 2. alquil-(C0-C6)-N(R8)-C(O)-O-alquil-(C1-C6), en donde R8 es (i) un átomo de hidrógeno, o (ii) -alquil- (C1-C6), en donde alquilo está no sustituido o está sustituido una, dos o tres veces, independientemente entre sí, con -NH2, -CN. -OH, -C(O)-OH, -C(O)-O-alquil-(C1-C6), -C(O)-NH-OH, NO2 o halógeno, o (iii) OH, 3. -(C(O)-N(R9)-(R10), en donde R9 y R10 son idénticos o diferentes y son, independientemente entre sí, (i) un átomo de hidrógeno, o (ii) -alquil-(C1-C6), o R9 y R10 forman, junto con el átomo de nitrógeno al que están unidos, un anillo saturado de 5, 6 ó 7 miembros, en el que un heteroátomo de la serie oxígeno, azufre y nitrógeno puede reemplazar también uno o dos átomos de carbono adicionales y, en el caso del nitrógeno, los átomos de nitrógeno pueden estar no sustituidos o estar sustituidos, de forma independiente entre sí, con alquilo-(C1-C6), 4. -aril-(C6-C14), en donde arilo está sustituido una, dos o tres veces, independientemente entre sí, con 4.1) -alquil-(C0-C6)-C(O)-O-R8, en donde R8 tiene el significado anteriormente mencionado, 4.2) -alquil-(C0-C6)-C(O)-N(R9)-(R10), en donde R9 y R10 tienen los significados anteriormente mencionados, 4.3) -alquil-(C0-C6)-C(O)-NH-CN, ...
CO05041024A 2002-11-02 2005-04-29 Nuevas diamidas del acido pirimidin-4, 6-dicarboxilixo para la inhibicion selectiva de colagenasas CO5700759A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10251019A DE10251019A1 (de) 2002-11-02 2002-11-02 Neue Pyrimidin-4,6-dicarbonsäurediamide zur selektiven Inhibierung von Kollagenasen
DE10254092A DE10254092A1 (de) 2002-11-20 2002-11-20 Neue Pyrimidin-4,6-dicarbonsäurediamide zur selektiven Inhibierung von Kollagenasen

Publications (1)

Publication Number Publication Date
CO5700759A2 true CO5700759A2 (es) 2006-11-30

Family

ID=32313538

Family Applications (1)

Application Number Title Priority Date Filing Date
CO05041024A CO5700759A2 (es) 2002-11-02 2005-04-29 Nuevas diamidas del acido pirimidin-4, 6-dicarboxilixo para la inhibicion selectiva de colagenasas

Country Status (25)

Country Link
EP (1) EP1560815B1 (es)
JP (1) JP4564359B2 (es)
KR (1) KR101050680B1 (es)
AR (1) AR043058A1 (es)
AT (1) ATE388941T1 (es)
AU (1) AU2003301847A1 (es)
BR (1) BR0315055A (es)
CA (1) CA2504153C (es)
CO (1) CO5700759A2 (es)
DE (1) DE50309381D1 (es)
DK (1) DK1560815T3 (es)
ES (1) ES2298621T3 (es)
HK (1) HK1083503A1 (es)
HR (1) HRP20050382B1 (es)
MA (1) MA27412A1 (es)
MX (1) MXPA05004365A (es)
MY (1) MY135375A (es)
NO (1) NO330345B1 (es)
PE (1) PE20040605A1 (es)
PL (1) PL375044A1 (es)
PT (1) PT1560815E (es)
RS (1) RS20050294A (es)
RU (1) RU2344129C2 (es)
TW (1) TWI316512B (es)
WO (1) WO2004041788A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060173183A1 (en) * 2004-12-31 2006-08-03 Alantos Pharmaceuticals, Inc., Multicyclic bis-amide MMP inhibitors
US20070155738A1 (en) 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
US20060293345A1 (en) * 2005-05-20 2006-12-28 Christoph Steeneck Heterobicyclic metalloprotease inhibitors
US20080021024A1 (en) * 2006-06-29 2008-01-24 Alantos Pharmaceuticals Holding, Inc. Metalloprotease inhibitors
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
AR067354A1 (es) 2007-06-29 2009-10-07 Sunesis Pharmaceuticals Inc Compuestos utiles como inhibidores de la raf quinasa
AR068509A1 (es) * 2007-09-19 2009-11-18 Jerini Ag Antagosnistas del receptor de bradiquinina b1
US8912184B1 (en) 2010-03-01 2014-12-16 Alzheimer's Institute Of America, Inc. Therapeutic and diagnostic methods
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
CN103038214B (zh) 2010-04-22 2015-09-30 弗特克斯药品有限公司 制备环烷基甲酰胺基-吲哚化合物的方法
AR086113A1 (es) 2011-04-30 2013-11-20 Abbott Lab Isoxazolinas como agentes terapeuticos
PL3925607T3 (pl) 2014-04-15 2023-10-30 Vertex Pharmaceuticals Incorporated Kompozycje farmaceutyczne do leczenia chorób, w których pośredniczy mukowiscydozowy przezbłonowy regulator przewodnictwa

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3931432A1 (de) * 1989-09-21 1991-04-04 Hoechst Ag Pyrimidin-4,6-dicarbonsaeurediamide, verfahren zu deren herstellung sowie verwendung derselben sowie arzneimittel auf basis dieser verbindungen
DOP2002000332A (es) * 2001-02-14 2002-08-30 Warner Lambert Co Inhibidores de piridina de metaloproteinasas de la matriz
JP2004518723A (ja) 2001-02-14 2004-06-24 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー ピリミジンマトリックスメタロプロテイナーゼ阻害剤
DE10160357A1 (de) * 2001-12-08 2003-06-18 Aventis Pharma Gmbh Verwendung von Pyridin-2,4-dicarbonsäurediamiden und Pyrimidin-4,6-dicarbonsäurediamiden zur selektiven Inhibierung von Kollagenasen

Also Published As

Publication number Publication date
RU2344129C2 (ru) 2009-01-20
MY135375A (en) 2008-04-30
AR043058A1 (es) 2005-07-13
JP2006513158A (ja) 2006-04-20
ATE388941T1 (de) 2008-03-15
RU2005116847A (ru) 2006-01-20
NO330345B1 (no) 2011-03-28
ES2298621T3 (es) 2008-05-16
PE20040605A1 (es) 2004-10-15
JP4564359B2 (ja) 2010-10-20
WO2004041788A1 (de) 2004-05-21
NO20052628D0 (no) 2005-05-31
HRP20050382A2 (en) 2006-12-31
AU2003301847A1 (en) 2004-06-07
BR0315055A (pt) 2005-08-16
EP1560815B1 (de) 2008-03-12
EP1560815A1 (de) 2005-08-10
DE50309381D1 (de) 2008-04-24
DK1560815T3 (da) 2008-06-16
PL375044A1 (en) 2005-11-14
HK1083503A1 (en) 2006-07-07
KR101050680B1 (ko) 2011-07-21
KR20050067212A (ko) 2005-06-30
MXPA05004365A (es) 2005-07-05
MA27412A1 (fr) 2005-06-01
CA2504153A1 (en) 2004-05-21
PT1560815E (pt) 2008-04-07
TW200418808A (en) 2004-10-01
TWI316512B (en) 2009-11-01
NO20052628L (no) 2005-07-08
HRP20050382B1 (hr) 2013-09-30
RS20050294A (en) 2007-11-15
CA2504153C (en) 2012-07-03

Similar Documents

Publication Publication Date Title
CO5700759A2 (es) Nuevas diamidas del acido pirimidin-4, 6-dicarboxilixo para la inhibicion selectiva de colagenasas
CO6220951A2 (es) 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso
CO5690585A2 (es) Uso de inhibidores de la ikb-quinasa para el tratamiento del dolor
AR107694A1 (es) Heteroarilos inhibidores de pad4
AR037300A2 (es) Piridinas 3-heteroalquilo-arilo substituidas, un procedimiento para su produccion, producto farmaceutico y el uso de dichos compuestos para la produccion de productos farmaceuticos
AR058077A1 (es) Derivados de acidos fenoxiaceticos
CO5640047A2 (es) Acidos fenoxiaceticos sustituidos como compuestos farmaceuticos utiles para el trtamiento de desordenes respiratorios, las composiciones farmaceuticas que los contienen y los procesos para su preparacion
CU20090070A7 (es) Nuevos derivados de sulfonamida como antagonistas de la bradiquinina
AR080803A1 (es) Derivados de 3,4-dihidro-1h-benzo[b][1,6]naftiridina, composiciones farmaceuticas que los contiene, procedimiento para prepararlos e intermediarios del mismo, y uso de los compuestos en el tratamiento de canceres y enfermedades autoinmunes e inflamatorias.
AR082825A2 (es) Inhibidores heterociclicos nitrogenados de mek, composiciones farmaceuticas que los contienen, metodos para prepararlos y uso de los mismos para el tratamiento de trastornos hiperproliferativos o inflamatorios
CO5690579A2 (es) Derivados de diarilcicloalquilo, metodo para su produccion y su uso como medicamentos
CO5540280A2 (es) Derivados aromaticos de acido dicarboxilico
GT200600398A (es) Compuestos de isoindol-imida y composiciones que los incluye y metodos para su uso
CU23218A3 (es) Derivados espirociclicos nuevos y su uso como inhibidores de fosfodiesterasa - 7
UY31679A1 (es) Inhibidores de cinasa pim y metodos para su uso
AR034282A1 (es) Derivados de difenilazetidinona, medicamentos que contienen estos compuestos, procedimiento para su preparacion, y su utilizacion para la preparacion de medicamentos
PA8792501A1 (es) Nuevos derivados de 6-triazolopiridacina-sulfanil benzotiazol y bencimidazol,su procedimiento de preparación,su aplicación como medicamentos,composiciones farmacéuticas y nueva utilización principalmente como inhibidores de met.
PA8799101A1 (es) Compuestos tienopirimidina y pirazolopirimidina y su uso como inhibidores de quinasa mtor y quinasa p13
AR035499A1 (es) Agentes antiinflamatorios
AR056686A1 (es) Derivados de diacilindazol como inhibidores de lipasas y fosfolipasas
CO5611131A2 (es) Derivados de 5-feniltiazol y su uso como inhibidores de pi3 cinasa
AR082850A1 (es) Aminopirazoloquinazolinas
AR049578A1 (es) Derivados de hidantoina, procesos de obtencion y composiciones farmaceuticas
SV2008002967A (es) Derivados de pirimidinil-aril-urea que son inhibidores de fgf
CO5640132A2 (es) Piridinonas sustituidas

Legal Events

Date Code Title Description
FC Application refused